Wells Fargo Maintains a Buy Rating on MannKind Corporation (MNKD), Sets a $9 PT

In This Article: MannKind Corporation (NASDAQ:MNKD) is one of the 13 Best Healthcare Stocks to Buy Under $10. On May 8, Wells Fargo analyst Tiago Fauth maintained a Buy rating on MannKind Corporation (NASDAQ:MNKD) and set a price target of $9.00. A close-up of a doctor's hand pressing on an…